Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Digital Health Congress 2025

The Digital Health World Congress 2025 is the must-attend event for healthcare professionals, medtech innovators, and AI-driven health technology pioneers. Taking place in the heart [...]

Go to Top